Skip to main content
. Author manuscript; available in PMC: 2010 Oct 21.
Published in final edited form as: Am J Kidney Dis. 1988 Feb;11(2):141–144. doi: 10.1016/s0272-6386(88)80199-9

Table 1.

Initial Randomized Trial Comparing High-Dose Steroids to Orthoclone OKT3 for the Treatment of Biopsy Proven Acute Cellular Rejection

No Reversal Rescue
Needed
Rescue
Successful
OKT3 7 6
Steroids 11 4 7 6/7

The trial was abandoned after only 18 patients because of the obvious superiority of Orthoclone OKT3